What will be main domestic pharmaceutical products of Amgen soon to be launched?
Domestic products of Amgen which will be officially launched have been visualized.
According to the industry concerned on the 12th, the Korean branch of Amgen turned in applications of ‘Kyprolis(carfilzomib),’ a multiple myeloma treatment, and ‘Blincyto(blinatumomab)’, an acute lymphoblastic leu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
